Coronary microcirculatory dysfunction in hypercholesterolemic patients with COVID-19: potential benefit from cholesterol-lowering treatment.
Ann Med
; 55(1): 2199218, 2023 12.
Article
in En
| MEDLINE
| ID: mdl-37068045
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/
COVID-19
/
Anticholesteremic Agents
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Ann Med
Journal subject:
MEDICINA
Year:
2023
Document type:
Article
Affiliation country:
Finlandia
Country of publication:
Reino Unido